Comments on Profile Post by FGG

Is this the sort of thing you are referring to? https://www.technologyreview.com/2019/08/22/133291/the-next-trick-for-crispr-is-gene-editing-pain-away/

Other than that, Flexion therapeutics' FX301 is a drug to look out for, set to initiate Phase 1b soon (Flexion acquired the rights to develop Xenon's XEN402)

@serendipity1996 . Yep. How's progress going on this?

Navega Therapeutics are working on this but they are in pre-clinical stages
https://navegatx.com/en
(Sorry for spamming you btw!)

@serendipity1996 , What? No. I asked and even considered tagging you :).